Aliases & Classifications for Hyperostosis

MalaCards integrated aliases for Hyperostosis:

Name: Hyperostosis 12 56 6 45 15 74
Hypertrophy of Bone 12
Bone Hypertrophy 12

Classifications:



External Ids:

Disease Ontology 12 DOID:205
MeSH 45 D015576
NCIt 51 C34712
SNOMED-CT 69 13814009
ICD10 34 M89.3 M89.30
UMLS 74 C0020492

Summaries for Hyperostosis

Disease Ontology : 12 A bone remodeling disease that results in an abnormal growth of located in bone.

MalaCards based summary : Hyperostosis, also known as hypertrophy of bone, is related to endosteal hyperostosis, autosomal dominant and tumoral calcinosis, hyperphosphatemic, familial, 1. An important gene associated with Hyperostosis is SOST (Sclerostin), and among its related pathways/superpathways are MicroRNAs in cardiomyocyte hypertrophy and Senescence and Autophagy in Cancer. The drugs Everolimus and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include bone, brain and lung, and related phenotypes are growth/size/body region and cellular

Wikipedia : 77 Hyperostosis is an excessive growth of bone. It may lead to exostosis. It occurs in many musculoskeletal... more...

Related Diseases for Hyperostosis

Diseases related to Hyperostosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 267)
# Related Disease Score Top Affiliating Genes
1 endosteal hyperostosis, autosomal dominant 33.9 ANKH LRP5 TNFRSF11B
2 tumoral calcinosis, hyperphosphatemic, familial, 1 33.5 FGF23 GALNT3 KL
3 osteopathia striata with cranial sclerosis 33.4 LRP5 TNFRSF11B
4 caffey disease 33.4 COL1A1 GALNT3
5 sclerosteosis 1 33.1 LRP4 SOST
6 sclerosteosis 33.1 COL1A1 LRP4 LRP5 SOST
7 van buchem disease 32.9 COL1A1 KREMEN1 LRP4 LRP5 SOST
8 craniodiaphyseal dysplasia 32.4 LRP5 SOST TGFB1
9 sclerosteosis 2 32.2 LRP4 LRP5 SOST
10 hyperphosphatemia 30.5 FGF23 GALNT3 KL
11 familial tumoral calcinosis 30.2 FGF23 GALNT3 KL
12 calcinosis 30.0 ANKH FGF23 GALNT3 KL
13 renal osteodystrophy 30.0 FGF23 SOST TNFRSF11B
14 chondrocalcinosis 29.6 ALPL ANKH TNFRSF11B
15 facial paralysis 29.6 ANKH LRP5 TGFB1
16 bone disease 28.6 ALPL COL1A1 FGF23 IGF1 LRP5 SOST
17 osteoporosis 28.1 ALPL COL1A1 FGF23 IGF1 KL LRP5
18 diffuse idiopathic skeletal hyperostosis 12.7
19 hyperostosis cranialis interna 12.6
20 hyperostosis frontalis interna 12.6
21 ankylosing vertebral hyperostosis with tylosis 12.5
22 calvarial hyperostosis 12.5
23 exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis 12.5
24 polyosteolysis-hyperostosis syndrome 12.2
25 dysplastic cortical hyperostosis 12.2
26 sapho syndrome 12.1
27 short stature cranial hyperostosis hepatomegaly 12.0
28 isolated sternocostoclavicular hyperostosis 12.0
29 paget disease of bone 5, juvenile-onset 11.8
30 camurati-engelmann disease 11.7
31 worth type autosomal dominant osteosclerosis 11.6
32 craniometaphyseal dysplasia, autosomal dominant 11.4
33 exostosis 11.3
34 ossification of the posterior longitudinal ligament of spine 11.3
35 lenz-majewski hyperostotic dwarfism 11.3
36 frontometaphyseal dysplasia 2 11.2
37 tumoral calcinosis, hyperphosphatemic, familial, 2 11.2
38 tumoral calcinosis, hyperphosphatemic, familial, 3 11.2
39 melorheostosis 11.1
40 weleber hecht bigley syndrome 11.1
41 craniodiaphyseal dysplasia, autosomal dominant 11.1
42 craniometaphyseal dysplasia, autosomal recessive 11.1
43 weismann-netter syndrome 11.0
44 melorheostosis, isolated 11.0
45 buschke-ollendorff syndrome 11.0
46 raine syndrome 11.0
47 bone inflammation disease 10.6
48 synovitis 10.6
49 dysphagia 10.6
50 neurofibromatosis, type ii 10.5

Graphical network of the top 20 diseases related to Hyperostosis:



Diseases related to Hyperostosis

Symptoms & Phenotypes for Hyperostosis

MGI Mouse Phenotypes related to Hyperostosis:

47 (show all 20)
# Description MGI Source Accession Score Top Affiliating Genes
1 growth/size/body region MP:0005378 10.37 ALPL ANKH COL1A1 COX4I2 FGF23 GALNT3
2 cellular MP:0005384 10.35 ALPL ANKH COL1A1 GALNT3 IGF1 KL
3 homeostasis/metabolism MP:0005376 10.32 ALPL ANKH COL1A1 COX4I2 FGF23 GALNT3
4 cardiovascular system MP:0005385 10.27 ALPL ANKH COL1A1 FGF23 GALNT3 IGF1
5 behavior/neurological MP:0005386 10.24 ALPL ANKH COL1A1 COX4I2 KL LRP4
6 limbs/digits/tail MP:0005371 10.22 ALPL ANKH COL1A1 FGF23 GALNT3 IGF1
7 craniofacial MP:0005382 10.21 ALPL ANKH COL1A1 GALNT3 KL LRP4
8 immune system MP:0005387 10.2 ALPL ANKH COL1A1 COX4I2 FGF23 GALNT3
9 endocrine/exocrine gland MP:0005379 10.19 ALPL COL1A1 FGF23 GALNT3 IGF1 KL
10 hematopoietic system MP:0005397 10.19 ALPL ANKH COL1A1 FGF23 GALNT3 IGF1
11 mortality/aging MP:0010768 10.11 ALPL ANKH COL1A1 FGF23 IGF1 KL
12 adipose tissue MP:0005375 10.07 ALPL COL1A1 IGF1 KL SLC39A14 TGFB1
13 digestive/alimentary MP:0005381 10.02 ALPL COL1A1 FGF23 GALNT3 KL TGFB1
14 integument MP:0010771 9.98 COL1A1 FGF23 GALNT3 IGF1 KL LRP4
15 muscle MP:0005369 9.92 ALPL ANKH COL1A1 GALNT3 IGF1 KL
16 hearing/vestibular/ear MP:0005377 9.91 ANKH COL1A1 IGF1 KL TNFRSF11B
17 reproductive system MP:0005389 9.85 ALPL ANKH COL1A1 FGF23 GALNT3 IGF1
18 renal/urinary system MP:0005367 9.8 COL1A1 FGF23 GALNT3 IGF1 KL LRP4
19 respiratory system MP:0005388 9.61 ALPL ANKH COL1A1 COX4I2 FGF23 IGF1
20 skeleton MP:0005390 9.47 ALPL ANKH COL1A1 FGF23 GALNT3 IGF1

Drugs & Therapeutics for Hyperostosis

Drugs for Hyperostosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 45)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Everolimus Approved Phase 2 159351-69-6 70789204 6442177
2
Miconazole Approved, Investigational, Vet_approved Phase 2 22916-47-8 4189
3
Sirolimus Approved, Investigational Phase 2 53123-88-9 46835353 5284616 6436030
4
leucovorin Approved Phase 2 58-05-9 143 6006
5
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
6
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
7
Tretinoin Approved, Investigational, Nutraceutical Phase 2 302-79-4 444795 5538
8 Anti-Infective Agents Phase 2
9 Immunologic Factors Phase 2
10 Antibiotics, Antitubercular Phase 2
11 Immunosuppressive Agents Phase 2
12 Anti-Bacterial Agents Phase 2
13 Antifungal Agents Phase 2
14 Antimetabolites, Antineoplastic Phase 2
15 Antimetabolites Phase 2
16 Immunoglobulins Phase 2
17 Vitamin B9 Phase 2
18 Dermatologic Agents Phase 2
19 Vitamin B Complex Phase 2
20 Folate Phase 2
21 Nucleic Acid Synthesis Inhibitors Phase 2
22 Antibodies Phase 2
23 Folic Acid Antagonists Phase 2
24 Antirheumatic Agents Phase 2
25 Antibodies, Monoclonal Phase 2
26
Pamidronate Approved Phase 1 40391-99-9 4674
27 Bone Density Conservation Agents Phase 1
28 Diphosphonates Phase 1
29
Sevelamer Approved 52757-95-6
30
Etanercept Approved, Investigational 185243-69-0
31
Alfacalcidol Approved, Nutraceutical 41294-56-8 5282181
32 Micronutrients
33 Trace Elements
34 Nutrients
35 Hydroxycholecalciferols
36 Vitamins
37 Chelating Agents
38 Analgesics
39 Peripheral Nervous System Agents
40 Anti-Inflammatory Agents
41 Analgesics, Non-Narcotic
42 Gastrointestinal Agents
43 Anti-Inflammatory Agents, Non-Steroidal
44 Insulin, Globin Zinc Not Applicable
45 insulin Not Applicable

Interventional clinical trials:

(show all 30)
# Name Status NCT ID Phase Drugs
1 Chronic Insertional Achilles Tendonitis Treated With or Without Flexor Hallucis Longus Tendon Transfer Completed NCT00950053 Phase 4
2 Flexible Footwear and Insole in Heel Pain Unknown status NCT03040557 Phase 1, Phase 2
3 Autologous Stem Cells in Achilles Tendinopathy Unknown status NCT02064062 Phase 2
4 Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation Completed NCT02428296 Phase 2 Sirolimus
5 Efficacy, Safety and Tolerability of AIN457 in Patients With Rheumatoid Arthritis (RA) Taking Methotrexate (MTX) Completed NCT00928512 Phase 2 Secukinmab;Placebo
6 An Efficacy and Safety Study of Palovarotene for the Treatment of MO Recruiting NCT03442985 Phase 2 Palovarotene 2.5 mg;Palovarotene 5.0 mg
7 Evaluation of an Acellular Osteochondral Graft for Cartilage LEsions Pilot Trial Terminated NCT01183637 Phase 2
8 Efficacy of Bisphosphonates in Patients With Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis (SAPHO) Syndrome Completed NCT02544659 Phase 1 pamidronate disodium
9 Hypophosphatemic Rickets in Norway Unknown status NCT01057186 Sevelamer
10 Evaluation of Effectiveness of Selected Physical and Kinesiotherapeutic Methods in Patients With Lower Calcaneal Spur Unknown status NCT02934100 Not Applicable
11 Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing Spondylitis Completed NCT01417455
12 Nottingham Osteoarthritis Biomarker Study 2011 Completed NCT01495455
13 Immune Response in the SAPHO Syndrome Completed NCT01688219
14 Clinical Observation Study With the SBG Stem Completed NCT02338661
15 The Effect of High Intensity Laser Therapy in the Management of Painful Calcaneal Spur Completed NCT03907085 Not Applicable
16 A Comparison of the Analgesic Efficacies of Ultrasound and Shock Wave Therapy in the Patients With Calcaneal Spur Completed NCT01510249
17 Effects of Myofascial Trigger Point Dry Cupping on Plantar Heel Pain Completed NCT02895698 Not Applicable
18 Effectiveness of Manual Therapy Combined With Standard Treatment in the Management of Plantar Fasciitis Completed NCT01439932 Not Applicable
19 Characterize Patients With Moderately Active Rheumatoid Arthritis (RA) Completed NCT01557322 methotrexate (MTX)
20 The Health-Related Quality of Life in Patients With Hereditary Multiple Exostoses Completed NCT00474448
21 Effect of Chosen Treatment Methods in Patients With Cervical Spine Osteoarthritis Completed NCT03683602 Not Applicable
22 NGS Strategy Effectiveness in Molecular Diagnosis Completed NCT03557567
23 Natural History, Pathogenesis and Outcome of Melorheostosis A Rare Osteosclerotic Disease Recruiting NCT02504879
24 Genetic and Functional Analysis of Craniometaphyseal Dysplasia (CMD) Recruiting NCT01630460
25 Analysis of a Tapered Porous Coated Stem and a Cementless Hemispherical Acetabular Component Recruiting NCT03168750 Not Applicable
26 The Effect of Kinesio-tape and Shock Wave Therapy on Plantar Fasciitis Recruiting NCT03904966 Not Applicable
27 Magnetic Resonance Imaging in High Risk Patients for the Development of Diffuse Idiopathic Skeletal Hyperostosis (DISH) Active, not recruiting NCT03237455 Not Applicable
28 Evaluation of Radiculitis Following Use of Bone Morphogenetic Protein-2 for Interbody Arthrodesis in Spinal Surgery Active, not recruiting NCT00984672
29 Gene Mutations and Orthopaedic Symptoms Correlation of Multiple Hereditary Exostoses: Multicentre Project Suspended NCT00474331
30 Establishing the Genetic Profile of Multiple Hereditary Exostoses (HME) in Families of BC Terminated NCT00473850

Search NIH Clinical Center for Hyperostosis

Cochrane evidence based reviews: hyperostosis

Genetic Tests for Hyperostosis

Anatomical Context for Hyperostosis

MalaCards organs/tissues related to Hyperostosis:

42
Bone, Brain, Lung, Heart, Spinal Cord, Kidney, Myeloid

Publications for Hyperostosis

Articles related to Hyperostosis:

(show top 50) (show all 1302)
# Title Authors Year
1
Diffuse idiopathic skeletal hyperostosis masquerading as asthma: case report. ( 31026818 )
2019
2
Diffuse idiopathic skeletal hyperostosis is associated with lumbar spinal stenosis requiring surgery. ( 29327302 )
2019
3
L5-S1 Charcot spine induced by diffuse idiopathic skeletal hyperostosis in chronic tetraplegia: 2 cases. ( 29920334 )
2019
4
Management of Airway Obstruction due to Diffuse Idiopathic Skeletal Hyperostosis in the Cervical Spine: A Case Report and Literature Review. ( 30146564 )
2019
5
Aortic pulsation prevents the development of ossification of anterior longitudinal ligament toward the aorta in patients with diffuse idiopathic skeletal hyperostosis (DISH) in Japanese: Results of chest CT-based cross-sectional study. ( 30232028 )
2019
6
Spinal fractures in patients with diffuse idiopathic skeletal hyperostosis: Clinical characteristics by fracture level. ( 30415821 )
2019
7
Spinal fractures in patients with Diffuse idiopathic skeletal hyperostosis:A nationwide multi-institution survey. ( 30679080 )
2019
8
Ectopic Spinal Calcification Associated with Diffuse Idiopathic Skeletal Hyperostosis (DISH): A Quantitative Micro-CT Analysis. ( 30756413 )
2019
9
Diffuse Idiopathic Skeletal Hyperostosis: A Case with Dysphonia, Dysphagia and Myelopathy. ( 30879018 )
2019
10
Criteria for Early-Phase Diffuse Idiopathic Skeletal Hyperostosis: Development and Validation. ( 30938626 )
2019
11
Diffuse idiopathic skeletal hyperostosis in smokers is associated with Restrictive Spirometry Pattern: an analysis in the COPDGene cohort. ( 31043539 )
2019
12
Spinal fractures in diffuse idiopathic skeletal hyperostosis: Advantages of percutaneous pedicle screw fixation. ( 31079563 )
2019
13
Cervical Alignment of Anterior Cervical Hyperostosis Causing Dysphagia. ( 30095794 )
2019
14
Monoclonal Gammopathy of Undetermined Significance in a Patient With Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis (SAPHO) Syndrome: Coincidence or Association? ( 30870251 )
2019
15
A Rare Case of Lethal Prenatal-Onset Infantile Cortical Hyperostosis. ( 31016912 )
2019
16
Complete heart block in a boy with hyperostosis-hyperphosphataemia syndrome: a case report. ( 31020248 )
2019
17
Remarks on the difusse idiopatic skeletal hyperostosis (Forestier Rotes-Querol disease). ( 31031046 )
2019
18
Stress fracture of the midshaft clavicle associated with sternocostoclavicular hyperostosis-Case report. ( 31035227 )
2019
19
Polyostotic cortical hyperostosis in an 8-week-old cat with a 3-year follow-up. ( 31044432 )
2019
20
The history of Arachne through historic descriptions of meningiomas with hyperostosis: from prehistory to the present. ( 31048045 )
2019
21
Large dural-based mass with bony hyperostosis in a 16-year-old male: IgG4-related disease mimicking lymphoplasmacyte-rich meningioma. ( 31073682 )
2019
22
Biallelic variants in POLR3GL cause endosteal hyperostosis and oligodontia. ( 31089205 )
2019
23
Serum levels of proinflammatory, anti-inflammatory cytokines, and RANKL/OPG in synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome. ( 29694253 )
2019
24
Cervical myelopathy revealing a unique case of retinoid hyperostosis. ( 30660805 )
2019
25
Efficacy of bisphosphonates in patients with synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome: a prospective open study. ( 30767869 )
2019
26
Hyperostosis frontalis interna as an age-related phenomenon - Differences between males and females and possible use in identification. ( 30798865 )
2019
27
Hypotrichosis with keratosis follicular and hyperostosis: a new phenotype due to GJA1 mutation. ( 30811667 )
2019
28
Thoracic aortic aneurysm is an independent factor associated with diffuse idiopathic skeletal hyperostosis. ( 29701101 )
2018
29
Images in Neuroscience: Calvarial hyperostosis associated with multiple intracranial tumours. ( 29428264 )
2018
30
Giant Bilateral Calvarial Hyperostosis Secondary to Small Unilateral Frontal Meningioma. ( 30271067 )
2018
31
Chronic Recurrent Multifocal Osteomyelitis (CRMO) and Synovitis Acne Pustulosis Hyperostosis Osteitis (SAPHO) Syndrome - Two Presentations of the Same Disease? ( 30390722 )
2018
32
Imaging Findings Suggestive of Axial Spondyloarthritis in Diffuse Idiopathic Skeletal Hyperostosis. ( 28371491 )
2018
33
Spinal fracture in diffuse idiopathic skeletal hyperostosis. ( 28986210 )
2018
34
Diffuse idiopathic skeletal hyperostosis (DISH): Increased prevalence in Pacific Islanders. ( 29024571 )
2018
35
The surgical management of dysphagia secondary to diffuse idiopathic skeletal hyperostosis. ( 29438856 )
2018
36
Traumatic spondyloptosis at the thoracolumbar junction in a patient with diffuse idiopathic skeletal hyperostosis: A case report. ( 29478625 )
2018
37
Diffuse Idiopathic Skeletal Hyperostosis Extended to the Lumbar Segment Is a Risk Factor of Reoperation in Patients Treated Surgically for Lumbar Stenosis. ( 29481381 )
2018
38
Diffuse Idiopathic Skeletal Hyperostosis-On the Wrong Side? ( 29481728 )
2018
39
Degenerative changes of the thoracic spine do exist in patients with diffuse idiopathic skeletal hyperostosis: a detailed thoracic spine CT analysis. ( 29482347 )
2018
40
Factors associated with bone metabolism in patients with cervical ossification of the posterior longitudinal ligament accompanied with diffuse idiopathic skeletal hyperostosis. ( 29547116 )
2018
41
Prevalence of Diffuse Idiopathic Skeletal Hyperostosis Diagnosed by Whole Spine Computed Tomography: A Preliminary Study. ( 29564046 )
2018
42
Bone mineral density changes over time in diffuse idiopathic skeletal hyperostosis of the thoracic spine. ( 29649655 )
2018
43
The Natural Course of Diffuse Idiopathic Skeletal Hyperostosis in the Thoracic Spine of Adult Males. ( 29657149 )
2018
44
Anterior longitudinal ligament in diffuse idiopathic skeletal hyperostosis: Ossified or displaced? ( 29667228 )
2018
45
Rich table but short life: Diffuse idiopathic skeletal hyperostosis in Danish astronomer Tycho Brahe (1546-1601) and its possible consequences. ( 29672561 )
2018
46
Simultaneous Bilateral Quadriceps Tendon Rupture in a Patient with Diffuse Idiopathic Skeletal Hyperostosis after Minimal Trauma: Eight-Year Follow-Up. ( 29682378 )
2018
47
Severe hip joint motion restriction in a patient with diffuse idiopathic skeletal hyperostosis: A case report. ( 29718882 )
2018
48
Prevalence of diffuse idiopathic skeletal hyperostosis (DISH) assessed with whole-spine computed tomography in 1479 subjects. ( 29848322 )
2018
49
Regional Differences in Diffuse Idiopathic Skeletal Hyperostosis: A Retrospective Cohort Study from Sweden and Japan. ( 29916957 )
2018
50
Esophageal incarceration associated with cervical vertebral fracture in a patient with diffuse idiopathic skeletal hyperostosis. ( 29935973 )
2018

Variations for Hyperostosis

ClinVar genetic disease variations for Hyperostosis:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 POLR3GL NM_032305.3(POLR3GL): c.326-1G> A single nucleotide variant Likely pathogenic GRCh38 Chromosome 1, 145977482: 145977482
2 POLR3GL NM_032305.3(POLR3GL): c.326-1G> A single nucleotide variant Likely pathogenic GRCh37 Chromosome 1, 145457605: 145457605
3 POLR3GL NM_001330685.1(POLR3GL): c.-41-1G> A single nucleotide variant Likely pathogenic rs782661984 GRCh38 Chromosome 1, 145974824: 145974824
4 POLR3GL NM_001330685.1(POLR3GL): c.-41-1G> A single nucleotide variant Likely pathogenic rs782661984 GRCh37 Chromosome 1, 145460264: 145460264

Expression for Hyperostosis

Search GEO for disease gene expression data for Hyperostosis.

Pathways for Hyperostosis

GO Terms for Hyperostosis

Cellular components related to Hyperostosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.76 ALPL COL1A1 FGF23 IGF1 KL SOST
2 extracellular matrix GO:0031012 9.26 ALPL COL1A1 TGFB1 TNFRSF11B
3 extracellular space GO:0005615 9.23 ALPL COL1A1 FGF23 IGF1 KL SOST

Biological processes related to Hyperostosis according to GeneCards Suite gene sharing:

(show all 19)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of protein kinase B signaling GO:0051897 9.76 FGF23 KL TGFB1
2 regulation of signaling receptor activity GO:0010469 9.72 FGF23 IGF1 KL TGFB1 TNFRSF11B
3 negative regulation of canonical Wnt signaling pathway GO:0090090 9.7 KREMEN1 LRP4 SOST
4 Wnt signaling pathway GO:0016055 9.67 KREMEN1 LRP4 LRP5 SOST
5 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.63 IGF1 LRP4 TGFB1
6 positive regulation of transcription, DNA-templated GO:0045893 9.63 COL1A1 FGF23 IGF1 LRP5 SOST TGFB1
7 fibroblast growth factor receptor signaling pathway GO:0008543 9.61 FGF23 GALNT3 KL
8 positive regulation of mitotic nuclear division GO:0045840 9.58 IGF1 LRP5
9 endochondral ossification GO:0001958 9.57 ALPL COL1A1
10 regulation of bone mineralization GO:0030500 9.56 ANKH FGF23
11 phosphate-containing compound metabolic process GO:0006796 9.55 FGF23 TGFB1
12 response to vitamin D GO:0033280 9.54 ALPL TGFB1
13 positive regulation of transcription regulatory region DNA binding GO:2000679 9.51 IGF1 TGFB1
14 response to magnesium ion GO:0032026 9.49 FGF23 TNFRSF11B
15 cell activation GO:0001775 9.48 IGF1 TGFB1
16 cellular response to parathyroid hormone stimulus GO:0071374 9.4 FGF23 SOST
17 skeletal system development GO:0001501 9.35 ALPL ANKH COL1A1 IGF1 TNFRSF11B
18 positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway GO:0090080 9.26 FGF23 KL
19 negative regulation of ossification GO:0030279 8.92 KREMEN1 LRP4 SOST TGFB1

Molecular functions related to Hyperostosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 growth factor activity GO:0008083 9.13 FGF23 IGF1 TGFB1
2 fibroblast growth factor receptor binding GO:0005104 8.62 FGF23 KL

Sources for Hyperostosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....